ADA 2026: New advances in diabetes care
ADA 2026 Scientific Sessions: Emerging therapies, new disease insights and personalised careExplore key findings from the ADA 2026 Scientific Sessions, including advances in type 5 diabetes, immunotherapy, stem cell-derived beta-cell therapy and next-generation treatments for diabetes and obesity.
> Read more